-

$undefined

N/A

(N/A)

Apogee Therapeutics :APGE

Location: | Industry: | Sector:


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

1.689B

Cash

520.7M

Avg Qtr Burn

-42.79M

Short % of Float

20.91%

Insider Ownership

11.37%

Institutional Own.

-

Qtr Updated

12/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
APG777 Details
Atopic dermatitis

Big Mover™

Susp. Mover™

Phase 2

Data readout

Phase 2

Initiation

APG808 Details
Allergic diseases Type 2, Chronic obstructive pulmonary disease, Asthma

Phase 1b

Data readout

APG279 (APG777 + APG990) Details
Atopic Dermatitis (AD)

Phase 1b

Initiation

APG990 Details
Atopic dermatitis

Phase 1

Data readout

APG333 Details
Asthma, Chronic obstructive pulmonary disease

Phase 1

Data readout